Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy

por Hao, Yuan-Yuan, Chen, Pan-Pan, Yuan, Xiang-Gui, Zhao, Ai-Qi, Liang, Yun, Liu, Hui, Qian, Wen-Bin
Publicado 2022